Methacholine
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Methacholine.svg | |
| Methacholine
| |
| Systematic (IUPAC) name | |
| 2-acetyloxypropyl-trimethyl-azanium | |
| Identifiers | |
| CAS number | 62-51-1 (chloride) |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C8H18NO2+ |
| Mol. mass | 160.234 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Methacholine chloride is a synthetic choline ester that acts as a non-selective muscarinic receptor agonist in the parasympathetic nervous system. It is highly active at all of the muscarinic receptors, but has little effect on the nicotinic receptors. Methacholine has a charged quaternary amine structure, rendering it insoluble to lipid cell membranes. Clinically, this means that it will not cross the blood-brain barrier and has poor absorption from the gastrointestinal tract. It is broken down at a relatively slow rate within the body, due to its resistance to acetylcholinesterases.
The primary clinical use of methacholine is to diagnose bronchial hyperreactivity, which occurs in asthma. This is accomplished through the methacholine challenge test. Other therapeutic uses are limited by its adverse cardiovascular effects, such as bradycardia and hypotension, which arise from its function as a cholinomimetic.
Use of methacholine, as well as all other muscarinic receptor agonists, is contraindicated in patients with coronary insufficiency, gastroduodenal ulcers, and incontinence. The parasympathomimetic action of this drug will exacerbate the symptoms of these disorders.
Brand Name
External links
The primary clinical use of methacholine is to diagnose bronchial hyperresponsiveness (due to either hypersensitivity or hyperreactivity).
References
- Katzung, Bertram G. (2004). Basic and Clinical Pharmacology, 9th. ISBN 0-07-141092-9.
- Lötvall J, Inman M, O'Byrne P (May 1998). "Measurement of airway hyperresponsiveness: new considerations". Thorax 53: 419–424. PMID 9708238.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
